Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

AstraZeneca laid out plans on Monday to switch to a direct listing of its shares in the United States, as the drugmaker seeks ...

The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, today announced a new ...

AstraZeneca said on Friday it will sell its diabetes and asthma drugs direct to cash-paying U.S. patients at a discount of up ...

AstraZeneca is the latest big pharma group to open up a Direct-To-Consumer (DTC) sales channel in the US, offering three of ...

By Charlie Conchie LONDON (Reuters) -AstraZeneca’s move to upgrade its listing in the U.S. risks pulling liquidity away from ...

AstraZeneca plans to upgrade its U.S. listing, retaining UK roots but expanding into the New York Stock Exchange. This move ...

AstraZeneca plans direct listing on New York Stock Exchange AstraZeneca to list directly in New York while keeping London ...

AstraZeneca Plc (NASDAQ: AZN) launched AstraZeneca Direct, an online platform designed to create a simple, convenient way for ...

AstraZeneca plans to list its shares in New York while keeping its London listing, a move that could allow easier access to ...

AstraZeneca is a leading global pharmaceutical company with strong growth in oncology, diversified revenues, and a robust ...

AstraZeneca aims to harmonize its share listings globally to enhance sustainable growth and investor reach, maintaining headquarters in the UK. Enhertu shows superior outcomes in early-stage ...